Sign Up to like & get
recommendations!
1
Published in 2019 at "Diabetes"
DOI: 10.1111/dom.13528
Abstract: We compared cardiovascular and other outcomes in patients with dysglycaemia with or without anti‐glutamic acid dehydrogenase (GAD) antibodies participating in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial. Of the 12 537 participants, 8162…
read more here.
Keywords:
anti gad;
origin trial;
gad positive;
standard care ... See more keywords